Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS CASAUBON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1447225495
CMS profile
20091
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$75.60

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $75.60 4

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $21.05 1
Abbott Laboratories $20.57 1
Novo Nordisk Inc $17.11 1
Intuity Medical Inc $16.87 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS CASAUBON

NPI 1447225495 · CMS profile ID 20091

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447225495?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447225495?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447225495?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1447225495?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $75.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $20.5712/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920468109 CMS
Intuity Medical Inc $16.8710/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905944825 CMS
ABBVIE INC. $21.0507/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890716405 CMS
Novo Nordisk Inc $17.1105/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899617731 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17.84 1
PY2021 $120.24 6
PY2022 $75.60 4
PY2023 $271.82 14
PY2024 $436.66 18
PY2025 $588.22 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $244,802.34 43
PY2024 Principal investigator $270,911.58 97
PY2023 Principal investigator $213,259.54 161
PY2022 Principal investigator $530,223.08 203
PY2021 Principal investigator $866,406.89 1,203
PY2020 Recipient $7,732.50 3
PY2020 Principal investigator $630,563.16 449
PY2019 Principal investigator $775,897.49 183

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

203 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Medtronic, Inc. $11,453.63 12/31/2022 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901717017
Principal investigator 1 Medtronic, Inc. $76,689.24 12/31/2022 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP331 Smart Pen No dispute reported 06/30/2026 901717021
Principal investigator 1 Medtronic, Inc. $11,067.08 12/31/2022 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP341 IMPACT2 No dispute reported 06/30/2026 901717025
Principal investigator 1 Novo Nordisk AS $23.06 12/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897134187
Principal investigator 1 Novo Nordisk AS $23.06 12/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897224885
Principal investigator 1 Novo Nordisk AS $962.44 12/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897134195
Principal investigator 1 Novo Nordisk AS $15.76 12/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897192045
Principal investigator 1 Novo Nordisk AS $787.50 12/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897214393
Principal investigator 1 Medtronic, Inc. $2,209.00 12/19/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705835
Principal investigator 1 Novo Nordisk AS $23.06 12/19/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897031885
Principal investigator 1 Medtronic, Inc. $252.00 12/15/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705831
Principal investigator 1 Novo Nordisk AS $23.06 12/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897218533
Principal investigator 1 Medtronic, Inc. $336.00 12/08/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705849
Principal investigator 1 Novo Nordisk AS $23.06 12/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897209461
Principal investigator 1 Novo Nordisk AS $23.06 12/06/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896960547
Principal investigator 1 Medtronic, Inc. $4,391.96 12/02/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703655
Principal investigator 1 Medtronic, Inc. $6,340.00 11/30/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 901696145
Principal investigator 1 Novo Nordisk AS $908.88 11/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897057723
Principal investigator 1 Novo Nordisk AS $1,063.12 11/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897214057
Principal investigator 1 Novo Nordisk AS $23.06 11/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897259769
Principal investigator 1 Medtronic, Inc. $2,095.00 11/23/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705847
Principal investigator 1 Novo Nordisk AS $1,964.27 11/23/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897096083
Principal investigator 1 Novo Nordisk AS $23.06 11/23/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897218529
Principal investigator 1 Novo Nordisk AS $23.06 11/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897209457
Principal investigator 1 Novo Nordisk AS $23.06 11/14/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897171709
Principal investigator 1 Novo Nordisk AS $23.06 11/09/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897171405
Principal investigator 1 Novo Nordisk AS $23.06 11/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897218525
Principal investigator 1 Medtronic, Inc. $4,478.32 11/02/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703653
Principal investigator 1 Novo Nordisk AS $9.99 10/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897098667
Principal investigator 1 Novo Nordisk AS $23.06 10/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897239679
Principal investigator 1 Novo Nordisk AS $708.75 10/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947489
Principal investigator 1 Novo Nordisk AS $500.00 10/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897096079
Principal investigator 1 Novo Nordisk AS $2,436.77 10/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897224889
Principal investigator 1 Medtronic, Inc. $5,819.00 10/19/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705845
Principal investigator 1 Medtronic, Inc. $210.00 10/18/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705843
Principal investigator 1 Novo Nordisk AS $23.06 10/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897224713
Principal investigator 1 Novo Nordisk AS $1,827.85 09/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897218521
Principal investigator 1 Novo Nordisk AS $300.00 09/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897224821
Principal investigator 1 Novo Nordisk AS $278.98 09/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896963977
Principal investigator 1 Novo Nordisk AS $1,411.32 09/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897031881
Principal investigator 1 Novo Nordisk AS $2,741.85 09/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897043555
Principal investigator 1 Novo Nordisk AS $23.06 09/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897171401
Principal investigator 1 Novo Nordisk AS $23.06 09/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897218537
Principal investigator 1 Medtronic, Inc. $2,861.00 09/21/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705841
Principal investigator 1 Novo Nordisk AS $23.06 09/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897061883
Principal investigator 1 Medtronic, Inc. $378.00 09/07/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705837
Principal investigator 1 Medtronic, Inc. $70.00 09/07/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705839
Principal investigator 1 Novo Nordisk AS $23.06 09/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897134191
Principal investigator 1 Medtronic, Inc. $2,204.00 09/02/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901705833
Principal investigator 1 Novo Nordisk AS $23.06 08/24/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897096075
Principal investigator 1 Medtronic, Inc. $588.00 08/22/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700087
Principal investigator 1 Novo Nordisk AS $800.55 08/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896950595
Principal investigator 1 Novo Nordisk AS $1,141.87 08/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897130389
Principal investigator 1 Novo Nordisk AS $2,553.77 08/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897134183
Principal investigator 1 Novo Nordisk AS $23.06 08/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897209465
Principal investigator 1 Medtronic, Inc. $2,696.36 08/16/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703651
Principal investigator 1 Medtronic, Inc. $1,465.56 08/15/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700085
Principal investigator 1 Novo Nordisk AS $23.06 08/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897171409
Principal investigator 1 Novo Nordisk AS $23.06 08/04/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897061879
Principal investigator 1 Medtronic, Inc. $2,771.19 08/02/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703649
Principal investigator 1 Novo Nordisk AS $1,141.87 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897013911
Principal investigator 1 Novo Nordisk AS $150.00 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897061875
Principal investigator 1 Novo Nordisk AS $2,454.21 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897171397
Principal investigator 1 Abbott Laboratories $255.00 07/15/2022 Non-covered Recipient Entity
Advarra Inc
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 914536745
Principal investigator 1 Medtronic, Inc. $3,600.00 07/15/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700083
Principal investigator 1 Medtronic, Inc. $388.62 07/14/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703647
Principal investigator 1 Medtronic, Inc. $894.00 07/11/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700081
Principal investigator 1 Novo Nordisk AS $23.06 07/08/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 897218517
Principal investigator 1 Novo Nordisk AS $23.06 07/05/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896950591
Principal investigator 1 Novo Nordisk AS $8.20 07/05/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897044711
Principal investigator 1 Novo Nordisk AS $745.88 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896975181
Principal investigator 1 Novo Nordisk AS $23.06 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896975185
Principal investigator 1 Novo Nordisk AS $150.00 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897100425
Principal investigator 1 Novo Nordisk AS $150.00 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213901
Principal investigator 1 Novo Nordisk AS $1,965.60 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213971
Principal investigator 1 Novo Nordisk AS $1,575.00 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897246565
Principal investigator 1 Novo Nordisk AS $25.00 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897258199
Principal investigator 1 Abbott Laboratories $1,000.00 06/27/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 914536553
Principal investigator 1 Medtronic, Inc. $101.60 06/27/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 901715225
Principal investigator 1 Novo Nordisk AS $23.06 06/23/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896975189
Principal investigator 1 Medtronic, Inc. $8,665.00 06/22/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700079
Principal investigator 1 Novo Nordisk AS $8.20 06/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897099621
Principal investigator 1 Novo Nordisk AS $23.06 06/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213909
Principal investigator 1 Medtronic, Inc. $2,325.52 06/14/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703645
Principal investigator 1 Novo Nordisk AS $23.06 06/13/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896948437
Principal investigator 1 Novo Nordisk AS $23.06 06/08/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896904237
Principal investigator 1 Novo Nordisk AS $8.20 06/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897100581
Principal investigator 1 Novo Nordisk AS $23.06 06/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897257331
Principal investigator 1 Medtronic, Inc. $894.00 06/04/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700077
Principal investigator 1 Novo Nordisk AS $23.06 05/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897013903
Principal investigator 1 Novo Nordisk AS $8.20 05/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897029921
Principal investigator 1 Medtronic, Inc. $7,517.00 05/25/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700073
Principal investigator 1 Medtronic, Inc. $1,398.00 05/25/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700075
Principal investigator 1 Novo Nordisk AS $23.06 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896901767
Principal investigator 1 Novo Nordisk AS $911.25 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 896930343
Principal investigator 1 Novo Nordisk AS $450.00 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896958749
Principal investigator 1 Novo Nordisk AS $1,591.88 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896972905
Principal investigator 1 Novo Nordisk AS $1,417.50 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897145419
Principal investigator 1 Novo Nordisk AS $23.06 05/24/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896947817
Principal investigator 1 Novo Nordisk AS $8.20 05/16/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947481
Principal investigator 1 Novo Nordisk AS $23.06 05/16/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947485
Principal investigator 1 Novo Nordisk AS $23.06 05/16/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897010545
Principal investigator 1 Novo Nordisk AS $8.20 05/16/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897257577
Principal investigator 1 Medtronic, Inc. $792.00 05/12/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700071
Principal investigator 1 Novo Nordisk AS $23.06 05/11/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896975477
Principal investigator 1 Novo Nordisk AS $23.06 05/05/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896958745
Principal investigator 1 Medtronic, Inc. $4,391.96 05/02/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703643
Principal investigator 1 Novo Nordisk AS $1,118.83 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896857507
Principal investigator 1 Novo Nordisk AS $250.00 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 896895533
Principal investigator 1 Novo Nordisk AS $1,100.25 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 896962191
Principal investigator 1 Novo Nordisk AS $46.12 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897191989
Principal investigator 1 Novo Nordisk AS $354.37 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897214389
Principal investigator 1 Medtronic, Inc. $13,857.00 04/26/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700069
Principal investigator 1 Novo Nordisk AS $23.06 04/08/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896948429
Principal investigator 1 Medtronic, Inc. $10,979.90 04/07/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901703657
Principal investigator 1 Novo Nordisk AS $23.06 03/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896904221
Principal investigator 1 Novo Nordisk AS $23.06 03/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896904225
Principal investigator 1 Novo Nordisk AS $200.00 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896857479
Principal investigator 1 Novo Nordisk AS $437.50 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896868151
Principal investigator 1 Novo Nordisk AS $450.00 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896904229
Principal investigator 1 Novo Nordisk AS $909.57 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896961189
Principal investigator 1 Novo Nordisk AS $437.50 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897145423
Principal investigator 1 Novo Nordisk AS $594.00 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897171911
Principal investigator 1 Novo Nordisk AS $200.00 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897214061
Principal investigator 1 Novo Nordisk AS $1,125.00 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897214441
Principal investigator 1 Novo Nordisk AS $1,050.00 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897239683
Principal investigator 1 Novo Nordisk AS $23.06 03/24/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896958741
Principal investigator 1 Medtronic, Inc. $13,358.00 03/23/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700067
Principal investigator 1 Medtronic, Inc. $672.00 03/16/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700065
Principal investigator 1 Novo Nordisk AS $23.06 03/14/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896901683
Principal investigator 1 Novo Nordisk AS $23.06 03/09/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896857477
Principal investigator 1 Abbott Laboratories $3,437.50 03/04/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 914537117
Principal investigator 1 Novo Nordisk AS $2,237.65 02/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896961185
Principal investigator 1 Novo Nordisk AS $741.19 02/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897100573
Principal investigator 1 Novo Nordisk AS $300.00 02/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897100577
Principal investigator 1 Novo Nordisk AS $2,136.94 02/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213905
Principal investigator 1 Novo Nordisk AS $1,188.00 02/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897259765
Principal investigator 1 Novo Nordisk AS $25.06 02/23/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896904233
Principal investigator 1 Novo Nordisk AS $25.06 02/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896901762
Principal investigator 1 Abbott Laboratories $140.00 02/18/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 914537137
Principal investigator 1 Medtronic, Inc. $13,308.00 02/18/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700063
Principal investigator 1 Abbott Laboratories $43,860.00 02/10/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 914536703
Principal investigator 1 Abbott Laboratories $94,200.44 02/10/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 914537213
Principal investigator 1 Novo Nordisk AS $25.06 02/09/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896901691
Principal investigator 1 Novo Nordisk AS $2,468.27 02/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896948425
Principal investigator 1 Novo Nordisk AS $694.12 02/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 896953655
Principal investigator 1 Novo Nordisk AS $1,625.00 02/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897100569
Principal investigator 1 Novo Nordisk AS $1,782.00 02/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213963
Principal investigator 1 Novo Nordisk AS $3,854.82 02/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897257621
Principal investigator 1 Medtronic, Inc. $420.00 02/04/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700061
Principal investigator 1 Novo Nordisk AS $25.06 02/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896901687
Principal investigator 1 Eli Lilly and Company $7,280.00 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 917841589
Principal investigator 1 Medtronic, Inc. $8,560.62 01/24/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 901715859
Principal investigator 1 Medtronic, Inc. $26,673.13 01/24/2022 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 901715861
Principal investigator 1 Medtronic, Inc. $29,896.70 01/24/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901715863
Principal investigator 1 Medtronic, Inc. $16,736.05 01/24/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901715865
Principal investigator 1 Eli Lilly and Company $1,500.00 01/14/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 917841577
Principal investigator 1 Eli Lilly and Company $1,500.00 01/14/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 917842507
Principal investigator 1 Medtronic, Inc. $3,914.00 01/13/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 901700059
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896868207
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896868211
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896868215
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947299
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947407
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947465
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896947477
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896950505
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896950579
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896950583
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 896950587
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897010469
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897013763
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897013819
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897013899
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897013907
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897029841
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897029845
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039488
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039491
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039497
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039499
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039503
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039507
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897044695
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897044701
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897044703
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897044709
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897097745
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897171903
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897172031
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213893
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213897
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897213967
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897239663
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897239667
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897257625
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897258195
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897259757
Principal investigator 1 Novo Nordisk AS $99.80 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897259761
Principal investigator 1 Novo Nordisk AS $500.00 01/12/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897260093
Principal investigator 1 Novo Nordisk AS $25.06 01/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 896972901
Principal investigator 1 Novo Nordisk AS $25.06 01/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897029837
Principal investigator 1 Novo Nordisk AS $2.97 01/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 897039484